-+ 0.00%
-+ 0.00%
-+ 0.00%

FDA GRANTS BREAKTHROUGH DEVICE DESIGNATION TO FREENOME’S BLOOD-BASED SIMPLESCREEN™ LUNG CANCER SCREENING TEST

Reuters·08/12/2026 13:00:01

Please log in to view news